Quantitative analysis of protective effect of erythropoietin on diabetic retinal cells using molecular hyperspectral imaging technology

IEEE Transactions on Biomedical Engineering

Volumn 57, Issue 7, 2010, Pages 1699-1706

  Li, Qingli ^a   Wang, Yiting ^a   Zhang, Jingfa ^b   Xu, Guotong ^b   Xue, Yongqi ^c  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI INSTITUTE OF TECHNICAL PHYSICS   (China)

Author keywords

Diabetic retinopathy; erythropoietin (EPO); molecular hyperspectral imaging (MHI); quantitative pathology

Indexed keywords

BIOINFORMATICS; IMAGE ENHANCEMENT; OPHTHALMOLOGY; PATHOLOGY; RAT CONTROL; RATS;

AFTER-TREATMENT; BIOCHEMICAL PARAMETERS; DIABETIC RATS; DIABETIC RETINOPATHY; ERYTHROPOIETIN (EPO); HYPER-SPECTRAL IMAGES; HYPERSPECTRAL IMAGING; NORMAL CONTROLS; OUTER NUCLEAR LAYERS; PROTECTIVE EFFECTS; QUANTITATIVE ANALYSIS; QUANTITATIVE INFORMATION; RETINAL CELLS; SPECTRAL TRANSMITTANCE;

EYE PROTECTION;

ERYTHROPOIETIN; PROTECTIVE AGENT;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFECT; EYE PROTECTION; IMAGING SYSTEM; MALE; MOLECULAR HYPERSPECTRAL IMAGING TECHNOLOGY; NONHUMAN; QUALITATIVE ANALYSIS; RAT; RETINA CELL; ANIMAL; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; MOLECULAR IMAGING; PATHOLOGY; PROCEDURES; RETINA; SPECTROSCOPY; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ERYTHROPOIETIN; HISTOCYTOCHEMISTRY; MALE; MOLECULAR IMAGING; PROTECTIVE AGENTS; RATS; RATS, WISTAR; RETINA; SPECTRUM ANALYSIS;

EID: 77953770547     PISSN: 00189294     EISSN: None     Source Type: Journal    
DOI: 10.1109/TBME.2010.2041663     Document Type: Article

References (58)

1. P. J. Watkins, "ABC of diabetes retinopathy," Brit. Med. J., vol.326, pp. 924-926, 2003.
2. E. Lieth, T. W. Gardner, A. J. Barber, and D. A. Antonetti, "Retinal neurodegeneration: Early pathology in diabetes," Clin. Exp. Ophthalmol., vol.28, pp. 3-8, 2000.
3. T. W. Gardner, D. A. Antonetti, A. J. Barber, K. F. LaNoue, and S. W. Levison, "Diabetic retinopathy: More than meets the eye," Surv. Ophthalmol., vol.47, pp. S253-S262, 2002.
4. A.W. Stitt, "The role of advanced glycation in the pathogenesis of diabetic retinopathy," Exp. Mol. Pathol., vol.75, pp. 95-107, 2003.
5. L. Smith, E. Wesolowski, A. McLellan, S. Kostyk, R. D'Amato, R. Sullivan, and P.D'Amore, "Oxygen-induced retinopathy in the mouse," Invest. Ophthalmol. Vis. Sci., vol.35, pp. 101-111, 1994.
6. H. Sone, Y. Kawakami, A. K. Kumagai, Y. Okuda, Y. Sekine, S. Honmura, T. Segawa, H. Suzuki, K. Yamashita, and N. Yamada, "Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy," Life Sci., vol.65, pp. 2573-2580, 1999.
7. D.Antonetti, E. Lieth,A. Barber, and T.Gardner, "Molecular mechanisms of vascular permeability in diabetic retinopathy," Semin. Ophthalmol., vol.14, pp. 240-248, 1999.
8. A. Stitt, H. Anderson, T. Gardiner, and D. Archer, "Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments," Brit. J. Ophthalmol., vol.78, pp. 133-137, 1994.
9. A. Stitt, T. Gardiner, and D. Archer, "Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients," Brit. J. Ophthalmol., vol.79, pp. 362-367, 1995.
10. T. A. Gardiner, D. B. Archer, T. M. Curtis, and A. W. Stitt, "Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis," Microcirculation, vol.14, pp. 25-38, 2007.
11. S. Yamagishi and T. Imaizumi, "Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy," Curr. Pharm. Des., vol.11, pp. 2279-2299, 2005.
12. J. Zhang, Y.Wu, Y. Jin, F. Ji, S. H. Sinclair, Y. Luo, G. Xu, L. Lu,W. Dai, M. Yanoff, W. Li, and G. Xu, "Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes," Invest. Ophthalmol. Vis. Sci., vol.49, pp. 732-742, 2008.
13. R. Simo, M. Garcia-Ramirez, M. Higuera, and C. Hernandez, "Apolipoprotein A1 Is overexpressed in the retina of diabetic patients," Amer. J. Ophthalmol., vol.147, pp. 319-325, 2009.
14. Z. Z. Chong, J. Q. Kang, andK.Maiese, "Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases," Circulation, vol.106, pp. 2973-2979, 2002.
15. L. Zhong, J. Bradley,W. Schubert, E. Ahmed, A. P. Adamis, D. T. Shima, G. S. Obinson, and Y. S. Ng, "Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice," Invest. Ophthalmol. Vis. Sci., vol.48, pp. 1212-1218, 2007.
16. A. C. Clermont and S.-E. Bursell, "Retinal blood flow in diabetes," Microcirculation, vol.14, pp. 49-61, 2007.
17. A. Stitt, N. Frizzell, and S. Thorpe, "Advanced glycation and advanced lipoxidation: Possible role in initiation and progression of diabetic retinopathy," Curr. Pharm. Des., vol.10, pp. 3349-3360, 2004.
18. A. B. Ackerman, "Discordance among expert pathologists in diagnosis of melanocytic neoplasm," Hum. Pathol., vol.27, pp. 1115-1116, 1996.
19. A. H. Schmieder, P. M. Winter, S. D. Caruthers, T. D. Harris, T. A. Williams, J. S. Allen, E. K. Lacy, H. Y. Zhang, M. J. Scott, G. Hu, J. D. Robertson, S. A. Wickline, and G. M. Lanza, "Molecular MR imaging of melanoma angiogenesis with alpha(nu)beta(3)-targeted paramagnetic nanoparticles," Magn. Reson. Med., vol.53, pp. 621-627, 2005.
20. S.-I. Lee, S. Y. Lee, K.-H. Yoon, K.-S. Choi, K. Y. Jang, W.-H. Yoo, S.-H. Kim, T. H. Choi, and J. G. Park, "Molecular MR imaging for visualizing ICAM-1 expression in the inflamed synovium of collagen-induced Arthritic mice," Korean J. Radiol., vol.10, pp. 472-480, 2009.
21. M. Palmowski, P. Peschke, J. Huppert, P. Hauff,M. Reinhardt, M. Maurer, C. P. Karger, M. Scholz, W. Semmler, P. E. Huber, and F. M. Kiessling, "Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions," Neoplasia, vol.11, pp. 856-863, 2009.
22. M. Thakur and B. C. Lentle, "Report of a summit on molecular imaging," Radiology, vol.236, pp. 753-755, 2005.
23. N. R. Jagannathan, "Molecular imaging in biomedical research," Curr. Sci., vol.92, pp. 1061-1070, 2007.
24. K. Sokolov, J. Aaron, B. Hsu, D. Nida, A. Gillenwater, M. Follen, C. MacAulay, K. Adler-Storthz, B. Korgel, M. Descour, R. Pasqualini, W. Arap, W. Lam, and R. Richards-Kortum, "Optical systems for in vivo molecular imaging of cancer," Technol. Cancer Res. Treat., vol.2, pp. 491-504, 2003.
25. J. K.Willmann, N. van Bruggen, and L.M. Dinkelborg, "Molecular imaging in drug development," Nat. Rev. Drug Discov., vol.7, pp. 591-607, 2008.
26. P. Cassidy and G. Radda, "Molecular imaging perspectives," J. Roy. Soc., vol.2, pp. 133-144, 2005.
27. A. T. Harris, "Spectral mapping tools from the earth sciences applied to spectral microscopy data," Cytometry A, vol.69a, pp. 872-879, 2006.
28. K. J. Zuzak, M. T. Gladwin, R. O. Cannon III, and I. W. Levin, "Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: Effects of nitric oxide," Amer. J. Physiol. Heart Circ. Physiol., vol.285, pp. H1183-H1189, 2003.
29. A. Papadakis, E. Stathopoulos, G. Delides, K. Berberides, G. Nikiforidis, and C. Balas, "A novel spectral microscope system: Application in quantitative pathology," IEEE Trans. Biomed. Eng., vol.50, no.2, pp. 207-217, Feb. 2003.
30. C. A. Barnes, V. L. Sutherland, J. A. Timlin, L. T. Nieman, J. F. Guzowski, M. K. Chawla, P. F. Worley, B. Roysam, B. L. McNaughton, and M. B. Sinclair, "Advanced imaging of multiple mRNAs in brain tissue using a custom hyperspectral imager and multivariate curve resolution," J. Neurosci. Methods, vol.160, pp. 144-148, 2007.
31. H. Bach, A. Renn, and U. P.Wild, "Spectral imaging of singlemolecules," Single Mol., vol.1, pp. 73-77, 2000.
32. Q. L. Li, Y. Q. Xue, G. H. Xiao, and J. F. Zhang, "Study on microscope hyperspectral medical imaging method for biomedical quantitative analysis," Chin. Sci. Bull., vol.53, pp. 1431-1434, 2008.
33. N. B. MacKinnon, M. Khojasteh, P. M. Lane, C. E. MacAulay, M. Guillaud, and U. Stange, "Hyperspectral imaging and spectral unmixing of stained tissue sections using a spectrally programmable light engine," Int. Soc. Opt. Eng. (SPIE), p. 64410A, 2007.
34. Q. L. Li and Z. Liu, "Tongue color analysis and discrimination based on hyperspectral images," Comput.Med. Imag. Graph., vol.33, pp. 217-221, 2009.
35. M. E. Gehm,M. S.Kim, and C. Fernandez, "High-throughput,multiplexed pushbroom hyperspectral microscopy," Opt. Exp., vol.16, pp. 11032-11043, 2008.
36. E. C. Kintner, "Method for the calculation of partially coherent imagery," Appl. Opt., vol.17, pp. 2747-2753, 1978.
37. H. H. Hopkins and P. M. Barham, "The influence of the condenser on microscopic resolution," Proc. Phys. Soc. Sect. B, vol.63, pp. 737-744, 1950.
38. K. J. Zuzak, M. D. Schaeberle, E. N. Lewis, and I. W. Levin, "Visible reflectance hyperspectral imaging: Characterization of a noninvasive, in vivo system for determining tissue perfusion," Anal. Chem., vol.74, pp. 2021-2028, 2002.
39. K. J. Zuzak, M. D. Schaeberle, M. T. Gladwin, R. O. Cannon, III, and I. W. Levin, "Noninvasive determination of spatially resolved and timeresolved tissue perfusion in humans during nitric oxide inhibition and inhalation by use of a visible-reflectance hyperspectral imaging technique," Circulation, vol.104, pp. 2905-2910, 2001.
40. M. Borengasser,W. Hungate, andR.Watkins, Hyperspectral Remote Sensing: Principles and Applications. Boca Raton, FL: CRC Press/Taylor & Francis, 2008.
41. G. Guyot, "Spectral signatures of objects. Report on activities of ISPRS working group VII-3: 16-20 December 1985, Les Arcs - France, and 18-22 January 1988, Aussois - France," ISPRS J. Photogram. Remote Sens., vol.44, pp. 295-301, 1990.
42. S. G. Coupland, "A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy," Doc. Ophthalmol., vol.66, pp. 207-218, 1987.
43. R. Rota, C. Chiavaroli, R. P. Garay, and P. Hannaert, "Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocindiabetic rats," Eur. J. Pharmacol., vol.495, pp. 217-224, Jul. 14, 2004.
44. H. van der Werff, F. van Ruitenbeek, M. van der Meijde, F. van der Meer, S. de Jong, and S. Kalubandara, "Rotation-variant template matching for supervised hyperspectral boundary detection," IEEE Geosci. Remote Sens. Lett., vol.4, no.1, pp. 70-74, Feb. 2007.
45. D.-M. Tsai and C.-H. Chiang, "Rotation-invariant pattern matching using wavelet decomposition," Pattern Recogn. Lett., vol.23, pp. 191-201, 2002.
46. L. X. Fan, P. Santago, W. Riley, and D. M. Herrington, "An adaptive template-matching method and its application to the boundary detection of brachial artery ultrasound scans," Ultrasound Med. Biol., vol.27, pp. 399-408, 2001.
47. V. Cantoni, I. De Lotto, and M. Ferretti, "A template-matching operator for edge-points detection in digital pictures," Signal Process., vol.4, pp. 349-360, 1982.
48. T. W. Gardner, D. A. Antonetti, A. J. Barber, K. F. LaNoue, and S. W. Levison, "Diabetic retinopathy: More than meets the eye," Surv. Ophthalmol., vol.47, pp. S253-S262, 2002.
49. A.-M. Joanna, O.-M. Jolanta, and M.-H. Marta, "Proliferative diabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system," Diabetes Res. Clin. Pract., vol.84, pp. 46-50, 2009.
50. F. A. Kruse, A. B. Lefkoff, and J.W. Boardman, "The spectral image processing system (SIPS)-software for integrated analysis of AVIRIS data," in Proc. Sum., 1992, pp. 23-25.
51. B. Park,W. R.Windhama, K. C. Lawrencea, and D. P. Smitha, "Contaminant classification of poultry hyperspectral imagery using a spectral angle mapper algorithm," Biosyst. Eng., vol.96, pp. 323-333, 2007.
52. F. A. Kruse, A. B. Lefkoff, J. W. Boardman, K. B. Heidebrecht, A. T. Shapiro, P. J. Barloon, and A. F. H. Goetz, "The spectral image processing system (SIPS)-Interactive visualization and analysis of imaging spectrometer data," Remote Sens. Environ., vol.44, pp. 145-163, 1993.
53. S.-E. Bursell, K. M. Della Vecchia, A. C. Clermont, J. Takahashi, C. L. Sundell, J. Luchoomun, F. H. Qiu, C. Kunsch, and L. P. Aiello, "Early diabetes-induced retinal vascular abnormalities are ameliorated by the antioxidant AGIX-4207 in diabetic rats," in Proc. Annu. Meet. Assoc.-Res.-Vis.-Ophthalmol., vol.45, Ft Lauderdale, FL, 2004, p. U84.
54. N. Ma, M. C. Madigan, T. Chan-Ling, and N. H. Hunt, "Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria," Glia, vol.19, pp. 135-151, 1997.
55. N. Goldenberg-Cohen, Y. Guo, F. Margolis, Y. Cohen, N. R. Miller, and S. L. Bernstein, "Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia," Invest. Ophthalmol. Vis. Sci., vol.46, pp. 2716-2725, 2005.
56. T. Murata, K. Nakagawa, A. Khalil, T. Ishibashi, H. Inomata, and K. Sueishi, "The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas," Lab. Invest., vol.74, pp. 819-825, 1996.
57. S. Ishida, T. Usui, K. Yamashiro, Y. Kaji, E. Ahmed, K. G. Carrasquillo, S. Amano, T. Hida, Y. Oguchi, and A. P. Adamis, "VEGF(164) is proinflammatory in the diabetic retina," Invest. Ophthalmol. Vis. Sci., vol.44, pp. 2155-2162, 2003.
58. C. Bucolo, K. W.Ward, E. Mazzon, S. Cuzzocrea, and F. Drago, "Protective effects of a coumarin derivative in diabetic rats," Invest. Ophthalmol. Vis. Sci., vol.50, pp. 3846-3852, 2009.